Published in J Nucl Med on October 01, 2006
Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut (2007) 1.92
Classification and management of refractory coeliac disease. Gut (2010) 1.48
Evaluation of Cladribine treatment in refractory celiac disease type II. World J Gastroenterol (2011) 1.04
Utility of positron emission tomography/CT in the evaluation of small bowel pathology. Br J Radiol (2012) 1.00
Celiac disease and autoimmunity in the gut and elsewhere. Gastroenterol Clin North Am (2008) 0.99
The management of primary small bowel and colon lymphoma--a review. Int J Colorectal Dis (2011) 0.90
Management of Enteropathy-Associated T-Cell Lymphoma: An Algorithmic Approach. Case Rep Oncol (2009) 0.86
The management of refractory coeliac disease. Ther Adv Chronic Dis (2013) 0.83
Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma. Oncologist (2014) 0.81
Mechanisms and management of refractory coeliac disease. Nat Rev Gastroenterol Hepatol (2015) 0.80
Improving outcomes of refractory celiac disease - current and emerging treatment strategies. Clin Exp Gastroenterol (2016) 0.75
2D ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy T cell lymphoma. BMC Gastroenterol (2013) 0.75
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet (2007) 8.50
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging (2010) 7.82
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet (2002) 3.67
The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging (2008) 3.24
Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ (2010) 2.94
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients. Clin Cancer Res (2006) 2.71
Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys (2005) 2.62
Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol (2002) 2.56
Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet (2009) 2.15
Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA (2010) 1.99
Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods. Mol Imaging Biol (2003) 1.86
Receptor conversion in distant breast cancer metastases. Breast Cancer Res (2010) 1.85
Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. Radiology (2005) 1.84
Frequent delay of coeliac disease diagnosis in symptomatic patients with type 1 diabetes mellitus: clinical and genetic characteristics. Eur J Intern Med (2013) 1.59
Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II. Gut (2012) 1.52
Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. Eur J Cancer (2005) 1.46
FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy. Eur J Nucl Med Mol Imaging (2006) 1.44
Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis. Dig Liver Dis (2010) 1.43
The European experience with double-balloon enteroscopy: indications, methodology, safety, and clinical impact. Gastrointest Endosc (2005) 1.41
Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities. Eur J Nucl Med Mol Imaging (2002) 1.36
Blood-brain barrier P-glycoprotein function in Alzheimer's disease. Brain (2011) 1.33
Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study. J Nucl Med (2009) 1.26
The value of double-balloon enteroscopy in patients with refractory celiac disease. Am J Gastroenterol (2007) 1.19
Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases. Cancer (2012) 1.18
Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study. World J Gastroenterol (2013) 1.14
Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study. Eur J Nucl Med Mol Imaging (2003) 1.13
18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study. J Nucl Med (2010) 1.13
Quantitative parametric perfusion images using 15O-labeled water and a clinical PET/CT scanner: test-retest variability in lung cancer. J Nucl Med (2010) 1.11
Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer. J Nucl Med (2005) 1.11
18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer. J Clin Oncol (2004) 1.04
Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study. Int J Cancer (2013) 1.02
Transluminal endoscopic step-up approach versus minimally invasive surgical step-up approach in patients with infected necrotising pancreatitis (TENSION trial): design and rationale of a randomised controlled multicenter trial [ISRCTN09186711]. BMC Gastroenterol (2013) 1.02
MR enteroclysis in refractory celiac disease: proposal and validation of a severity scoring system. Radiology (2011) 1.00
Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer. Ann Surg (2002) 0.97
Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET? Oral Oncol (2005) 0.95
Gluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2α/DQ8β transdimer. J Immunol (2011) 0.95
Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [¹¹C]docetaxel and positron emission tomography. Clin Cancer Res (2013) 0.95
Neutrophil recruitment and barrier impairment in celiac disease: a genomic study. Clin Gastroenterol Hepatol (2007) 0.93
Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results. Eur J Nucl Med Mol Imaging (2009) 0.90
Bone metabolism after total hip revision surgery with impacted grafting: evaluation using H2 15O and [18F]fluoride PET; a pilot study. Mol Imaging Biol (2008) 0.89
Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood (2008) 0.88
Video capsule endoscopy in patients with nonresponsive celiac disease. J Clin Gastroenterol (2013) 0.87
Type 1 diabetes and celiac disease in adults: glycemic control and diabetic complications. Acta Diabetol (2012) 0.87
Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases. Nucl Med Commun (2010) 0.86
Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease--proceedings of the first Thiopurine Task Force meeting. Dig Liver Dis (2010) 0.86
The SPINK gene family and celiac disease susceptibility. Immunogenetics (2007) 0.84
Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior? Eur Arch Otorhinolaryngol (2003) 0.84
Increased expression of the tight junction molecule claudin-18 A1 in both experimental colitis and ulcerative colitis. Inflamm Bowel Dis (2008) 0.83
DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT. Cancer Prev Res (Phila) (2011) 0.83
Double balloon endoscopy in GI hemorrhage. Gastrointest Endosc (2007) 0.83
Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg (2013) 0.83
PET-CT after radiofrequency ablation of colorectal liver metastases: suggestions for timing and image interpretation. Eur J Radiol (2013) 0.83
Temperature-controlled radiofrequency energy (SECCA) to the anal canal for the treatment of faecal incontinence offers moderate improvement. Eur J Gastroenterol Hepatol (2007) 0.82
Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy: incidence and outcomes. J Thorac Oncol (2012) 0.82
Microvessel density and p53 in detecting cervical cancer by FDG PET in cases of suspected recurrence. Eur J Nucl Med Mol Imaging (2006) 0.82
Initial experience with a prototype dual-crystal (LSO/NaI) dual-head coincidence camera in oncology. Eur J Nucl Med Mol Imaging (2004) 0.82
Endoscopic ultrasound guided fine-needle aspiration and 18FDG-positron emission tomography in the evaluation of patients with non-small cell lung cancer. Interact Cardiovasc Thorac Surg (2007) 0.82
Pseudomelanosis coli and adenomatous polyps. J Gastrointestin Liver Dis (2011) 0.81
Acute experimental colitis and human chronic inflammatory diseases share expression of inflammation-related genes with conserved Ets2 binding sites. Inflamm Bowel Dis (2009) 0.81
Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients. Clin Immunol (2005) 0.81
Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method. Radiother Oncol (2008) 0.81
Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia. Hepatology (2008) 0.80
[Fluorodeoxyglucose F18(FDG)-probe guided biopsy]. Ned Tijdschr Geneeskd (2010) 0.80
Interobserver agreement on the radiological criteria of the International Panel on the diagnosis of multiple sclerosis. Eur Radiol (2006) 0.80
Absolute quantification of [(11)C]docetaxel kinetics in lung cancer patients using positron emission tomography. Clin Cancer Res (2011) 0.80
18F-fluorodeoxyglucose positron emission tomography in elderly patients with an elevated erythrocyte sedimentation rate of unknown origin. PLoS One (2013) 0.79
The pathogenesis of pneumothorax in Birt-Hogg-Dubé syndrome: a hypothesis. Respirology (2014) 0.79
On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance. Curr Drug Metab (2009) 0.79
Rotavirus and coeliac autoimmunity among adults with non-specific gastrointestinal symptoms. Saudi Med J (2010) 0.79
The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases. BMC Med Imaging (2014) 0.78
Changes in natural Foxp3(+)Treg but not mucosally-imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the circulation of celiac disease patients. PLoS One (2013) 0.78
Endoscopic ultrasound in patients with obstructive jaundice and inconclusive ultrasound and computer tomography findings. Eur J Gastroenterol Hepatol (2006) 0.78
Hepatic steatosis in morbidly obese patients undergoing gastric bypass surgery: assessment with open-system 1H-MR spectroscopy. AJR Am J Roentgenol (2011) 0.78
The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease. Inflamm Bowel Dis (2016) 0.77
Seroprevalence of celiac disease in patients with autoimmune hepatitis. Eur J Gastroenterol Hepatol (2014) 0.77
Interobserver variability in chest CT and whole body FDG-PET screening for distant metastases in head and neck cancer patients. Mol Imaging Biol (2011) 0.77
18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma. Br J Haematol (2003) 0.77
DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients. J Immunol (2011) 0.77
Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment. J Crohns Colitis (2012) 0.77
Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease. Ther Drug Monit (2015) 0.77
[Guideline 'Coeliac disease and dermatitis herpetiformis']. Ned Tijdschr Geneeskd (2010) 0.76
Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis. BMC Gastroenterol (2011) 0.76
Post-colonoscopy massive air leakage with full body involvement: an impressive complication with uneventful recovery. Am J Gastroenterol (2009) 0.75
Comment on: Leeds et al. High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care 2011;34:2158-2163. Diabetes Care (2012) 0.75
The true ligand of the NOD2 receptor is peptidoglycan instead of lipopolysaccharide: a schematic representation of ligand-receptor interactions and NF-kappa B activation. Gastroenterology (2004) 0.75
Small bowel: from sideline to center stage in gastroenterology. Dig Dis (2015) 0.75
Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of Corticosteroids. Dig Dis (2017) 0.75
Retrospective attenuation correction of PET data for radiotherapy planning using a free breathing CT. Radiother Oncol (2007) 0.75
The petrified lung: an obscure cause of dyspnea in chronic renal failure revealed by bone scintigraphy. Am J Respir Crit Care Med (2013) 0.75
The African Middle Eastern Society for Digestive Oncology mission against viral hepatitis and hepatocellular carcinoma. Arab J Gastroenterol (2013) 0.75
Small intestinal diverticulitis. Clin Gastroenterol Hepatol (2010) 0.75
[Colorectal cancer screening in the Netherlands: which faecal occult blood test?]. Ned Tijdschr Geneeskd (2013) 0.75
Development of antibodies against humanized antitumor necrosis factor and loss of efficacy in a black spider monkey with inflammatory bowel disease. J Clin Rheumatol (2009) 0.75
Interobserver agreement between on-call radiology residents and radiology specialists in the diagnosis of pulmonary embolism using computed tomography pulmonary angiography. J Comput Assist Tomogr (2009) 0.75
Accessory findings on F-18 FDG positron emission tomography in bronchogenic carcinoma. Clin Nucl Med (2003) 0.75
Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy. Inflamm Bowel Dis (2017) 0.75